Biotech Startup Immuneel Therapeutics Secures Rs 100 Crore Investment
The Bengaluru-based cancer therapy business will distribute 10 equity shares and up to 8,164 Series A2 Compulsorily Convertible Preference shares as part of the deal. Immuneel Therapeutics, a cancer-focused biotech…